Skip to main content

Stepan Co (SCL) Stock Forecast

Data as of Sep 21, 2026

Basic Materials · Current price $61.78 (-1.73%)

Consensus Target
$75.00
Upside
+37.6%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $75.00High $75.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

SCL vs Sector & Market

MetricSCLBasic Materials AvgLarge Cap Avg
Analyst Rating2.002.352.42
Analyst Count1718
Target Upside+37.6%+146.7%+21.5%
P/E Ratio25.50-8.1038.34

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$633M$644M$655M1
2026-12-31$607M$617M$628M1
2027-03-31$662M$674M$685M1
2027-06-30$679M$691M$703M1
2027-09-30$657M$669M$680M1
2027-12-31$630M$641M$652M1
2028-12-31$2.60B$2.65B$2.71B1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$1.03$1.05$1.071
2026-12-31$0.66$0.67$0.681
2027-03-31$1.06$1.08$1.111
2027-06-30$1.22$1.25$1.271
2027-09-30$1.09$1.12$1.141
2027-12-31$0.68$0.70$0.711
2028-12-31$0.00$0.00$0.000

Frequently Asked Questions

What is the analyst consensus for SCL?

The consensus among 1 analysts covering Stepan Co (SCL) is Buy with an average price target of $75.00.

What is the highest price target for SCL?

The highest analyst price target for SCL is $75.00.

What is the lowest price target for SCL?

The lowest analyst price target for SCL is $75.00.

How many analysts cover SCL?

1 analysts have issued ratings for Stepan Co in the past 12 months.

Is SCL a buy or sell right now?

Based on 1 analyst ratings, SCL has a consensus rating of Buy (2.00/5) with a +37.6% upside to the consensus target of $75.00.

What are the earnings estimates for SCL?

Analysts estimate SCL will report EPS of $1.05 for the period ending 2026-09-30, with revenue estimated at $644M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.